← FDA Drug Approvals (Drugs@FDA)
VYVGART HYTRULO
BLA · Biologics License Application · Sponsor: ARGENX BV · Approved 2023-06-20
Drug application
- FDA Application #
BLA761304- Application type
- Biologics License Application
- Brand name
- VYVGART HYTRULO
- Generic name
- EFGARTIGIMOD ALFA AND HYALURONIDASE (HUMAN RECOMBINANT)
- Active ingredients
- EFGARTIGIMOD ALFA AND HYALURONIDASE-QVFC
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- ARGENX BV
- Manufacturer
- argenx US
- First approval
- 2023-06-20
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown